Categories

How BioPharma Can Improve Consumers’ Experience and Health

Patients as health consumers now know what “good” looks like in their digital experiences. People have tasted the convenience and respect they feel from well-designed, streamlined omnichannel retail experiences, and they now expect this from health care — specifically supported by the pharmaceutical companies who manufacture the medicines they use in managing chronic conditions, we learn in ixlayer ixInsights 2025: Pharma’s Role in Improving the Health Experience from ixlayer and Ipaos.             The patient-focused report gets specific about people dealing with asthma, COPD, Type 2 diabetes, heart disease, psoriasis, and atopic dermatitis with a lens on

 

What is a Consumer Health Company? Riffing Off of Deloitte’s Report on CHCs/A 2Q2025 Look at Self-Care Futures

By Jane Sarasohn-Kahn on 1 April 2025 in Aging, Aging and Technology, AI, AI and health, Artificial intelligence, Augmented intelligence, Baby Boomers and Health, Banks and health, Big Tech, Bio/life sciences, Bioethics, Boomers, Business and health, Chronic care, Chronic disease, Climate change, Connected health, Consumer electronics, Consumer experience, Consumer-directed health, Corporate responsibility, Corporate wellness, Data analytics and health, Demographics and health, Design and health, Diagnostics, Diet and health, Digital health, Digital therapeutics, Digital transformation, Environment and heatlh, ESG and health, FDA, Financial health, Financial wellness, Fitness, Food and health, Food as medicine, Future of health care, Global Health, Grocery stores, Health access, Health apps, Health at home, Health benefits, Health care industry, Health citizenship, Health Consumers, Health costs, Health ecosystem, Health engagement, Health insurance, Health marketing, Health media, Health Plans, Health policy, Health politics, Health privacy, Health Quality, Health regulation, Healthcare access, Healthcare DIY, Home care, Home economics, Home health, Hospital to home, medical home, Medical innovation, Medical technology, Misinformation and health, Mobile apps, Money and health, Nutrition, Omnichannel healthcare, OTCs, Out of pocket costs, Participatory health, Patient engagement, Patient experience, Personal health finance, Personalized medicine, Pharmacists, Pharmacy, Popular culture and health, Population health, Prescription drugs, Prevention and wellness, Primary care, Privacy and security, Public health, Remote health monitoring, Retail health, Self-care, Seniors and health, Shopping and health, Social health, Social responsibility, Sustainability, Techquity, Telehealth, Travel and health, Trust, Value based health, Virtual health, Wellbeing

The health care landscape in 2030 will feature an expanded consumer health industry that will become, “an established branch of the health ecosystem focused on promoting health, preventing, disease, treating symptoms and extending healthy longevity,” according to a report published by Deloitte in September 2024, Accelerating the future: The rise of a dynamic consumer health market. While this report hit the virtual bookshelf about six months ago, I am revisiting it on this first day of the second quarter of 2025 because of its salience in this moment of uncertainties across our professional and personal lives — particularly related to